BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2930706)

  • 1. Cell kinetics in acute lymphoblastic leukaemia: comparative analysis between adults and children.
    Ffrench M; Magaud JP; Manel AM; Adeleine P; Devaux Y; Fiere D; Philippe N; Souillet G; Bryon PA
    Br J Cancer; 1989 Mar; 59(3):401-6. PubMed ID: 2930706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an accumulation of cells during G2 in some acute lymphoblastic leukaemias?
    Ffrench M; Magaud JP; Arzounian M; Souchier C; Charrin C; Bryon PA
    Cell Tissue Kinet; 1990 Jul; 23(4):251-60. PubMed ID: 1697222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult acute lymphoblastic leukaemia: is cell proliferation related to other clinical and biological features?
    Ffrench M; Manel AM; Magaud JP; Fiere D; Adeleine P; Guyotat D; Bryon PA
    Br J Haematol; 1987 Apr; 65(4):419-23. PubMed ID: 3472588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
    Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
    Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cycle prognostic value in adult acute myeloid leukemia. The choice of the best variables.
    Ffrench M; Bryon PA; Fiere D; Vu Van H; Guyotat D; Extra JM; Viala JJ
    Leuk Res; 1986; 10(1):51-7. PubMed ID: 3456073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood acute lymphoblastic leukaemia; epidemiology and clinicopathological features.
    Yasmeen N; Ashraf S
    J Pak Med Assoc; 2009 Mar; 59(3):150-3. PubMed ID: 19288940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood.
    Scarffe JH; Hann IM; Evans DI; Morris Jones P; Palmer MK; Lilleyman JS; Crowther D
    Br J Cancer; 1980 May; 41(5):764-71. PubMed ID: 7000111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of peripheral blood S + G2/M phase size in adult acute non-lymphoblastic leukaemia.
    Guerci A; Pierrez J; Kohler F; Guerci O
    Eur J Haematol; 1989 Jul; 43(1):15-21. PubMed ID: 2767239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute lymphoblastic leukaemia in childhood: cell proliferation without rest.
    Hirt A; Antic V; Wang E; Lüthy AR; Leibundgut K; von der Weid N; Tobler A; Wagner HP
    Br J Haematol; 1997 Feb; 96(2):366-8. PubMed ID: 9029026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
    Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
    Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
    Ciudad J; San Miguel JF; López-Berges MC; Vidriales B; Valverde B; Ocqueteau M; Mateos G; Caballero MD; Hernández J; Moro MJ; Mateos MV; Orfao A
    J Clin Oncol; 1998 Dec; 16(12):3774-81. PubMed ID: 9850021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impulse cytophotometry studies of bone marrow and blood cells in children with acute lymphoblastic leukemia (ALL). 2. Lymphatic cells in blood].
    Exadaktylos P; Schlette O; Rumler W; Weidhase R; Haerting J; Reiss T; Heinrichs I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):617-23. PubMed ID: 2448200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
    Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
    Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
    Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.